Europe — EMA

Oxaliplatino Accord

Oxaliplatin, the active ingredient in Oxaliplatino Accord, is a platinum‑based chemotherapy agent presented as a sterile powder for intravenous infusion use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatino Accord, is a platinum‑based chemotherapy agent presented as a sterile powder for intravenous infusion use. It treats colorectal cancer in adult patients, typically as part of combination regimens.

GNH USA supplies Oxaliplatino Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Oxaliplatin used for?

Oxaliplatin is a platinum‑based chemotherapy drug that interferes with DNA replication across the colorectal cancer pathway as well as other treatment gifts but only …

- Colorectal cancer: ... ... .... - ... - ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →